m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00520)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
ENO1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | mouse embryonic stem cells | Mus musculus |
Treatment: METTL3-/- ESCs
Control: Wild type ESCs
|
GSE145309 | |
Regulation |
|
logFC: -8.80E-01 p-value: 3.03E-81 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Alpha-enolase (ENO1) positively correlated with METTL3 and global m6A levels, and negatively correlated with ALKBH5 in human Lung adenocarcinoma(LUAD). In addition, m6A-dependent elevation of ENO1 was associated with LUAD progression. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Lung adenocarcinoma | ICD-11: 2C25.0 | ||
Pathway Response | Carbon metabolism | hsa01200 | ||
Glycolysis / Gluconeogenesis | hsa00010 | |||
Cell Process | Glycolysis | |||
In-vitro Model | PC-9 | Lung adenocarcinoma | Homo sapiens | CVCL_B260 |
NCI-H441 | Lung papillary adenocarcinoma | Homo sapiens | CVCL_1561 | |
NCI-H292 | Lung mucoepidermoid carcinoma | Homo sapiens | CVCL_0455 | |
NCI-H2030 | Lung adenocarcinoma | Homo sapiens | CVCL_1517 | |
NCI-H1975 | Lung adenocarcinoma | Homo sapiens | CVCL_1511 | |
NCI-H1650 | Minimally invasive lung adenocarcinoma | Homo sapiens | CVCL_1483 | |
NCI-H1299 | Lung large cell carcinoma | Homo sapiens | CVCL_0060 | |
3LL | Malignant tumors of the mouse pulmonary system | Mus musculus | CVCL_5653 | |
HCC827 | Lung adenocarcinoma | Homo sapiens | CVCL_2063 | |
Calu-1 | Lung squamous cell carcinoma | Homo sapiens | CVCL_0608 | |
BEAS-2B | Normal | Homo sapiens | CVCL_0168 | |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
A-427 | Lung adenocarcinoma | Homo sapiens | CVCL_1055 | |
16HBE14o- | Normal | Homo sapiens | CVCL_0112 | |
In-vivo Model | KP and Mettl3-/- mice were bred to generate KPM-/- mice. Afterwards, the KP and KPM-/- mice were intranasally infected under anesthesia with adeno-associated virus type 5 (AAV5) expressing Cre to initiate lung tumorigenesis along with ALKBH5-expressing AAV5 or Empty AAV5 to generate KPE, KPA, KPEM-/- and KPAM-/- spontaneous LUAD mouse models. For generation of LLC-based intra-pulmonary tumor mouse models, 1 × 107 LLC cells were injected into C57BL/6 mice via the tail vein.For cell-derived xenograft (CDX) mouse models, 1.0 × 107 H1299 or 1.5 × 107 H1975 cells were subcutaneously injected into 4-6-week-old athymic nude mice. The tumors were monitored at indicated time points and isolated for further analysis after sacrifice. | |||
RNA demethylase ALKBH5 (ALKBH5) [ERASER]
Representative RNA-seq result indicating the expression of this target gene regulated by ALKBH5 | ||
Cell Line | human pluripotent stem cells | Homo sapiens |
Treatment: hILO ALKBH5knockout cells
Control: hILO wild type cells
|
GSE163945 | |
Regulation |
|
logFC: -9.52E-01 p-value: 3.98E-04 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Alpha-enolase (ENO1) positively correlated with METTL3 and global m6A levels, and negatively correlated with ALKBH5 in human Lung adenocarcinoma(LUAD). In addition, m6A-dependent elevation of ENO1 was associated with LUAD progression. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Lung adenocarcinoma | ICD-11: 2C25.0 | ||
Pathway Response | Carbon metabolism | hsa01200 | ||
Glycolysis / Gluconeogenesis | hsa00010 | |||
Cell Process | Glycolysis | |||
In-vitro Model | PC-9 | Lung adenocarcinoma | Homo sapiens | CVCL_B260 |
NCI-H441 | Lung papillary adenocarcinoma | Homo sapiens | CVCL_1561 | |
NCI-H292 | Lung mucoepidermoid carcinoma | Homo sapiens | CVCL_0455 | |
NCI-H2030 | Lung adenocarcinoma | Homo sapiens | CVCL_1517 | |
NCI-H1975 | Lung adenocarcinoma | Homo sapiens | CVCL_1511 | |
NCI-H1650 | Minimally invasive lung adenocarcinoma | Homo sapiens | CVCL_1483 | |
NCI-H1299 | Lung large cell carcinoma | Homo sapiens | CVCL_0060 | |
3LL | Malignant tumors of the mouse pulmonary system | Mus musculus | CVCL_5653 | |
HCC827 | Lung adenocarcinoma | Homo sapiens | CVCL_2063 | |
Calu-1 | Lung squamous cell carcinoma | Homo sapiens | CVCL_0608 | |
BEAS-2B | Normal | Homo sapiens | CVCL_0168 | |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
A-427 | Lung adenocarcinoma | Homo sapiens | CVCL_1055 | |
16HBE14o- | Normal | Homo sapiens | CVCL_0112 | |
In-vivo Model | KP and Mettl3-/- mice were bred to generate KPM-/- mice. Afterwards, the KP and KPM-/- mice were intranasally infected under anesthesia with adeno-associated virus type 5 (AAV5) expressing Cre to initiate lung tumorigenesis along with ALKBH5-expressing AAV5 or Empty AAV5 to generate KPE, KPA, KPEM-/- and KPAM-/- spontaneous LUAD mouse models. For generation of LLC-based intra-pulmonary tumor mouse models, 1 × 107 LLC cells were injected into C57BL/6 mice via the tail vein.For cell-derived xenograft (CDX) mouse models, 1.0 × 107 H1299 or 1.5 × 107 H1975 cells were subcutaneously injected into 4-6-week-old athymic nude mice. The tumors were monitored at indicated time points and isolated for further analysis after sacrifice. | |||
Wilms tumor 1-associating protein (WTAP) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by WTAP | ||
Cell Line | Human umbilical vein endothelial cells | Homo sapiens |
Treatment: siWTAP HUVECs
Control: siControl HUVECs
|
GSE167067 | |
Regulation |
|
logFC: -6.99E-01 p-value: 1.98E-02 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [2] | |||
Response Summary | The stabilization of WTAP further promotes RNA m6A methylation of Alpha-enolase (ENO1), impacting the glycolytic activity of BC cells. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Breast cancer | ICD-11: 2C60 | ||
Pathway Response | Glycolysis / Gluconeogenesis | hsa00010 | ||
Cell Process | Glycolysis | |||
In-vitro Model | MDA-MB-231 | Breast adenocarcinoma | Homo sapiens | CVCL_0062 |
MCF-7 | Invasive breast carcinoma | Homo sapiens | CVCL_0031 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
In-vivo Model | A total of 1 × 106 luciferase-labeled BC cells transfected with shWTAP or shNC were injected subcutaneously with or without C5aR1 neutrophils (tumor cells:neutrophils, 10:1). | |||
Lung cancer [ICD-11: 2C25]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Alpha-enolase (ENO1) positively correlated with METTL3 and global m6A levels, and negatively correlated with ALKBH5 in human Lung adenocarcinoma(LUAD). In addition, m6A-dependent elevation of ENO1 was associated with LUAD progression. | |||
Responsed Disease | Lung adenocarcinoma [ICD-11: 2C25.0] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | Carbon metabolism | hsa01200 | ||
Glycolysis / Gluconeogenesis | hsa00010 | |||
Cell Process | Glycolysis | |||
In-vitro Model | PC-9 | Lung adenocarcinoma | Homo sapiens | CVCL_B260 |
NCI-H441 | Lung papillary adenocarcinoma | Homo sapiens | CVCL_1561 | |
NCI-H292 | Lung mucoepidermoid carcinoma | Homo sapiens | CVCL_0455 | |
NCI-H2030 | Lung adenocarcinoma | Homo sapiens | CVCL_1517 | |
NCI-H1975 | Lung adenocarcinoma | Homo sapiens | CVCL_1511 | |
NCI-H1650 | Minimally invasive lung adenocarcinoma | Homo sapiens | CVCL_1483 | |
NCI-H1299 | Lung large cell carcinoma | Homo sapiens | CVCL_0060 | |
3LL | Malignant tumors of the mouse pulmonary system | Mus musculus | CVCL_5653 | |
HCC827 | Lung adenocarcinoma | Homo sapiens | CVCL_2063 | |
Calu-1 | Lung squamous cell carcinoma | Homo sapiens | CVCL_0608 | |
BEAS-2B | Normal | Homo sapiens | CVCL_0168 | |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
A-427 | Lung adenocarcinoma | Homo sapiens | CVCL_1055 | |
16HBE14o- | Normal | Homo sapiens | CVCL_0112 | |
In-vivo Model | KP and Mettl3-/- mice were bred to generate KPM-/- mice. Afterwards, the KP and KPM-/- mice were intranasally infected under anesthesia with adeno-associated virus type 5 (AAV5) expressing Cre to initiate lung tumorigenesis along with ALKBH5-expressing AAV5 or Empty AAV5 to generate KPE, KPA, KPEM-/- and KPAM-/- spontaneous LUAD mouse models. For generation of LLC-based intra-pulmonary tumor mouse models, 1 × 107 LLC cells were injected into C57BL/6 mice via the tail vein.For cell-derived xenograft (CDX) mouse models, 1.0 × 107 H1299 or 1.5 × 107 H1975 cells were subcutaneously injected into 4-6-week-old athymic nude mice. The tumors were monitored at indicated time points and isolated for further analysis after sacrifice. | |||
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Alpha-enolase (ENO1) positively correlated with METTL3 and global m6A levels, and negatively correlated with ALKBH5 in human Lung adenocarcinoma(LUAD). In addition, m6A-dependent elevation of ENO1 was associated with LUAD progression. | |||
Responsed Disease | Lung adenocarcinoma [ICD-11: 2C25.0] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Down regulation | |||
Pathway Response | Carbon metabolism | hsa01200 | ||
Glycolysis / Gluconeogenesis | hsa00010 | |||
Cell Process | Glycolysis | |||
In-vitro Model | PC-9 | Lung adenocarcinoma | Homo sapiens | CVCL_B260 |
NCI-H441 | Lung papillary adenocarcinoma | Homo sapiens | CVCL_1561 | |
NCI-H292 | Lung mucoepidermoid carcinoma | Homo sapiens | CVCL_0455 | |
NCI-H2030 | Lung adenocarcinoma | Homo sapiens | CVCL_1517 | |
NCI-H1975 | Lung adenocarcinoma | Homo sapiens | CVCL_1511 | |
NCI-H1650 | Minimally invasive lung adenocarcinoma | Homo sapiens | CVCL_1483 | |
NCI-H1299 | Lung large cell carcinoma | Homo sapiens | CVCL_0060 | |
3LL | Malignant tumors of the mouse pulmonary system | Mus musculus | CVCL_5653 | |
HCC827 | Lung adenocarcinoma | Homo sapiens | CVCL_2063 | |
Calu-1 | Lung squamous cell carcinoma | Homo sapiens | CVCL_0608 | |
BEAS-2B | Normal | Homo sapiens | CVCL_0168 | |
A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
A-427 | Lung adenocarcinoma | Homo sapiens | CVCL_1055 | |
16HBE14o- | Normal | Homo sapiens | CVCL_0112 | |
In-vivo Model | KP and Mettl3-/- mice were bred to generate KPM-/- mice. Afterwards, the KP and KPM-/- mice were intranasally infected under anesthesia with adeno-associated virus type 5 (AAV5) expressing Cre to initiate lung tumorigenesis along with ALKBH5-expressing AAV5 or Empty AAV5 to generate KPE, KPA, KPEM-/- and KPAM-/- spontaneous LUAD mouse models. For generation of LLC-based intra-pulmonary tumor mouse models, 1 × 107 LLC cells were injected into C57BL/6 mice via the tail vein.For cell-derived xenograft (CDX) mouse models, 1.0 × 107 H1299 or 1.5 × 107 H1975 cells were subcutaneously injected into 4-6-week-old athymic nude mice. The tumors were monitored at indicated time points and isolated for further analysis after sacrifice. | |||
Breast cancer [ICD-11: 2C60]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [2] | |||
Response Summary | The stabilization of WTAP further promotes RNA m6A methylation of Alpha-enolase (ENO1), impacting the glycolytic activity of BC cells. | |||
Responsed Disease | Breast cancer [ICD-11: 2C60] | |||
Target Regulator | Wilms tumor 1-associating protein (WTAP) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | Glycolysis / Gluconeogenesis | hsa00010 | ||
Cell Process | Glycolysis | |||
In-vitro Model | MDA-MB-231 | Breast adenocarcinoma | Homo sapiens | CVCL_0062 |
MCF-7 | Invasive breast carcinoma | Homo sapiens | CVCL_0031 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
In-vivo Model | A total of 1 × 106 luciferase-labeled BC cells transfected with shWTAP or shNC were injected subcutaneously with or without C5aR1 neutrophils (tumor cells:neutrophils, 10:1). | |||
References